A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Clinical trial NCT05956626 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05956626
- Sponsor
- Ocugen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2026-09-28
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.